Cargando…
PSMG3‐AS1 enhances glioma resistance to temozolomide via stabilizing c‐Myc in the nucleus
Glioblastoma (GBM) is the main form of primary brain malignancies with a dismal prognosis partly due to its invasive growth and rapid relapse. GBM frequently developed resistance to current standard‐of‐care therapeutic modalities, including surgery, radiation and chemotherapy, of which temozolomide...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120888/ https://www.ncbi.nlm.nih.gov/pubmed/35380741 http://dx.doi.org/10.1002/brb3.2531 |